Cited 1 times in
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.